| Line Item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Profit or loss [abstract] | ||||||
| Product and service revenue | ||||||
| License and other revenue | ||||||
| Other income | ||||||
| Cost of product and service revenue | ||||||
| Research and development expenses | ||||||
| General and administrative expenses | ||||||
| Operating (loss) / profit | ||||||
| Finance income | ||||||
| Finance costs | ||||||
| Exchange rate differences | ||||||
| Net gain on modification and extinguishment of financial liabilities | ||||||
| Non-operating (loss) / profit | ||||||
| (Loss) / profit before taxes | ||||||
| Income tax (expense) / benefit | ||||||
| (Loss) / profit for the period | ||||||
| Item that will be reclassified to profit or loss in subsequent periods: | ||||||
| Exchange rate differences on translation of foreign operations | ||||||
| Total comprehensive (loss) /profit | ||||||
| (Loss) / profit per share | ||||||
| Basic (loss) / profit for the period per share (in dollars per share) | ||||||
| Diluted (loss) / profit for the period per share (in dollars per share) | — |